Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
Journal of Medicinal Chemistry
|
April 21, 2021
A Modular Synthetic Route Involving <i>N</i>-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents
Hongfen Yang, Shivani Kundra, Michaelle Chojnacki, et al.
Molecular Cancer Therapeutics
|
August 5, 2017
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
Marisa A Fuse, Stephani Klingeman Plati, Sarah S Burns, et al.
Redox Biology
|
February 5, 2022
Peroxynitrite nitration of Tyr 56 in Hsp90 induces PC12 cell death through P2X7R-dependent PTEN activation
Megan Jandy, Asra Noor, Pascal Nelson, et al.
Neuro-Oncology
|
January 8, 2019
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development
Marisa A Fuse, Christine T Dinh, Jeremie Vitte, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
Journal of Medicinal Chemistry
|
April 21, 2021
A Modular Synthetic Route Involving <i>N</i>-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents
Hongfen Yang, Shivani Kundra, Michaelle Chojnacki, et al.
Molecular Cancer Therapeutics
|
August 5, 2017
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
Marisa A Fuse, Stephani Klingeman Plati, Sarah S Burns, et al.
Redox Biology
|
February 5, 2022
Peroxynitrite nitration of Tyr 56 in Hsp90 induces PC12 cell death through P2X7R-dependent PTEN activation
Megan Jandy, Asra Noor, Pascal Nelson, et al.
Neuro-Oncology
|
January 8, 2019
Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development
Marisa A Fuse, Christine T Dinh, Jeremie Vitte, et al.
Page
of 10